GO:0160044 sulfate:chloride antiporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160044 (sulfate:chloride antiporter activity) is a molecular function that enables the coupled exchange of chloride and sulfate across a membrane, as defined by the reaction chloride(in) + sulfate(out) = chloride(out) + sulfate(in).
• This antiporter activity is electrogenic and can be regulated by protons, as shown in lobster hepatopancreatic brush-border membrane vesicles.
• The human sulfate anion transporter hsat-1 (SLC26A1) is a key protein exhibiting sulfate:chloride antiporter activity.
• The erythrocyte band 3 protein (SLC4A1) mediates rapid electrogenic sulfate-chloride exchange, which can be chemically modified.
• Mutations in the diastrophic dysplasia sulfate transporter (DTDST/SLC26A2) cause undersulfation of proteoglycans and skeletal dysplasias such as achondrogenesis type 1B.
• Studying this activity is relevant for understanding sulfate homeostasis, skeletal development, and detoxification processes in various organisms.
Description
Sulfate:chloride antiporter activity (GO:0160044) is a molecular function that mediates the exchange of sulfate and chloride ions across biological membranes. This activity is crucial for maintaining ionic balance and sulfate homeostasis in cells, and it is observed in diverse organisms from crustaceans to humans. The antiporter operates electrogenically, meaning the exchange is influenced by the membrane potential and can be regulated by protons. In human physiology, sulfate:chloride antiporter activity is essential for proper sulfation of macromolecules such as proteoglycans, which are critical for cartilage and bone development. Dysregulation of this activity has been linked to skeletal disorders, highlighting its biomedical importance. Researchers study this function to understand membrane transport mechanisms, ion homeostasis, and related diseases.
sulfate:chloride antiporter activity At A Glance
| GO ID | GO:0160044 |
|---|---|
| GO term | sulfate:chloride antiporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Mediates the exchange of chloride and sulfate ions across membranes |
| Reaction | chloride(in) + sulfate(out) = chloride(out) + sulfate(in) |
| Electrogenicity | Electrogenic, as shown in lobster hepatopancreatic vesicles |
| Regulation | Can be regulated by protons (H+) |
| Key proteins | SLC26A1 (hsat-1), Band 3 (SLC4A1), DTDST (SLC26A2) |
What Is GO:0160044?
According to the Gene Ontology, sulfate:chloride antiporter activity (GO:0160044) enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: chloride(in) + sulfate(out) = chloride(out) + sulfate(in). In other words, it is a secondary active transport process where the inward movement of chloride is coupled to the outward movement of sulfate, or vice versa, across a lipid bilayer.
Why Is sulfate:chloride antiporter activity Important in Cell Biology?
Sulfate:chloride antiporter activity is vital for sulfate homeostasis, which is required for the sulfation of proteoglycans, steroids, and xenobiotics. Defects in this activity can lead to undersulfation of cartilage proteoglycans, causing skeletal dysplasias such as achondrogenesis type 1B and diastrophic dysplasia. Additionally, this antiporter activity is involved in detoxification and ion balance in various tissues, and its electrogenic nature allows it to respond to changes in membrane potential and pH. Understanding this function provides insights into membrane transport physiology and potential therapeutic targets for skeletal and metabolic disorders.
• Maintains sulfate homeostasis essential for proteoglycan sulfation in cartilage.
• Mutations in DTDST (SLC26A2) cause skeletal dysplasias like achondrogenesis type 1B.
• Mediates electrogenic exchange that can be regulated by protons.
• Involved in chloride and sulfate transport in erythrocytes via band 3.
• Human SLC26A1 (hsat-1) is a key sulfate transporter with antiporter activity.
• Contributes to detoxification and ion balance in hepatopancreatic tissues.
• Relevant for understanding arsenite oxidation in hot spring ecosystems.
• Potential target for modulating sulfate levels in disease states.
• Studied in the context of uranium mill tailings contamination.
• May influence citrate transport indirectly through ion gradients.
Mechanism, Genes and Research Methods
What Happens During sulfate:chloride antiporter activity?
In simple terms: The antiporter swaps chloride and sulfate ions across a membrane.
During sulfate:chloride antiporter activity, chloride ions move into the cell while sulfate ions move out, or vice versa, according to the reaction chloride(in) + sulfate(out) = chloride(out) + sulfate(in). This exchange is electrogenic, meaning it generates a net charge movement, as demonstrated in lobster hepatopancreatic brush-border membrane vesicles where the exchange was found to be electrogenic and regulated by protons. In human erythrocytes, band 3 mediates rapid electrogenic sulfate-chloride exchange, which can be modified chemically. The process is crucial for sulfate uptake and chloride efflux in various cell types.
Structure and Composition of sulfate:chloride antiporter activity
In simple terms: The antiporter is a membrane protein that forms a channel for ion exchange.
The proteins mediating sulfate:chloride antiporter activity are typically members of the SLC26 and SLC4 families. For example, the human sulfate anion transporter hsat-1 (SLC26A1) is a membrane protein that facilitates sulfate transport. Band 3 (SLC4A1) in erythrocytes is another well-characterized protein that mediates sulfate-chloride exchange. DTDST (SLC26A2) is a sulfate transporter whose mutations lead to skeletal dysplasias. These proteins are integral membrane proteins with multiple transmembrane domains that form the translocation pathway.
Molecular Mechanism of sulfate:chloride antiporter activity
In simple terms: The antiporter binds chloride and sulfate and flips them across the membrane.
The molecular mechanism involves the sequential binding of chloride and sulfate to the transporter, followed by conformational changes that translocate the ions across the membrane. The exchange is electrogenic, as shown by studies on lobster hepatopancreatic vesicles where the transport was influenced by membrane potential. In human erythrocytes, band 3-mediated sulfate-chloride exchange is rapid and electrogenic, and can be inhibited by chemical modification. The activity can be regulated by protons, suggesting a pH-dependent mechanism. The human hsat-1 protein exhibits sulfate transport activity that is likely coupled to chloride.
Regulation of sulfate:chloride antiporter activity
In simple terms: The antiporter can be turned on or off by changes in pH or other factors.
Sulfate:chloride antiporter activity is regulated by protons, as demonstrated in lobster hepatopancreatic brush-border membrane vesicles where H+ regulated the sulfate-chloride exchange. In human erythrocytes, the activity of band 3 can be modulated by chemical modifications, indicating potential regulatory sites. The expression and function of sulfate transporters like SLC26A1 may be regulated by cellular sulfate levels and developmental cues. Mutations in DTDST alter its transport activity, leading to disease.
Key Genes Involved in GO:0160044 sulfate:chloride antiporter activity
The following genes encode proteins that exhibit or are associated with sulfate:chloride antiporter activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC26A1 | Human sulfate anion transporter (hsat-1) mediating sulfate transport | Studied for sulfate homeostasis and transport mechanisms |
| SLC4A1 | Band 3 protein in erythrocytes mediating sulfate-chloride exchange | Model for electrogenic antiport and chemical modification |
| SLC26A2 | DTDST, sulfate transporter; mutations cause skeletal dysplasias | Linked to achondrogenesis type 1B and diastrophic dysplasia |
| SLC26A3 | Chloride/bicarbonate exchanger, may transport sulfate | Potential role in sulfate transport (not directly cited) |
| SLC26A4 | Pendrin, anion exchanger | May exhibit sulfate transport (not directly cited) |
| SLC26A6 | Anion exchanger | Potential sulfate transport (not directly cited) |
| SLC26A7 | Anion transporter | Potential sulfate transport (not directly cited) |
| SLC26A8 | Testis anion transporter | Potential sulfate transport (not directly cited) |
| SLC26A9 | Anion transporter | Potential sulfate transport (not directly cited) |
| SLC26A11 | Anion transporter | Potential sulfate transport (not directly cited) |
| SLC13A1 | Sodium-sulfate cotransporter | Not an antiporter but involved in sulfate transport (not directly cited) |
| SLC17A1 | Sodium-dependent phosphate transporter | Not directly cited |
| SLC22A6 | Organic anion transporter | Not directly cited |
| SLC22A8 | Organic anion transporter | Not directly cited |
| SLC4A2 | Anion exchanger | Not directly cited |
| SLC4A3 | Anion exchanger | Not directly cited |
| SLC4A4 | Electrogenic sodium bicarbonate cotransporter | Not directly cited |
How Is sulfate:chloride antiporter activity Regulated?
Sulfate:chloride antiporter activity is regulated by protons, as shown in lobster hepatopancreatic brush-border membrane vesicles where H+ influenced the exchange. In human erythrocytes, band 3-mediated sulfate-chloride exchange can be chemically modified, suggesting regulatory mechanisms. The expression of SLC26A1 may be regulated by sulfate availability. Mutations in DTDST alter its function, indicating that structural changes affect regulation.
sulfate:chloride antiporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC26A2 | Achondrogenesis type 1B, diastrophic dysplasia | Knockout or point mutation in chondrocytes |
| SLC4A1 | Erythrocyte ion homeostasis | Knockout in erythroid cells |
| SLC26A1 | Sulfate homeostasis | Overexpression in HEK293 cells |
| SLC26A2 | Undersulfation of proteoglycans | Knock-in of patient mutations |
| SLC26A1 | Potential metabolic disorders | CRISPR knockout in cell lines |
Skeletal Dysplasias
Mutations in the DTDST gene (SLC26A2), which encodes a sulfate transporter with sulfate:chloride antiporter activity, cause undersulfation of proteoglycans in cartilage, leading to skeletal dysplasias such as achondrogenesis type 1B and diastrophic dysplasia. A compound heterozygous mutation in DTDST can result in an intermediate phenotype between MED and DD. These findings highlight the critical role of sulfate transport in skeletal development.
Erythrocyte Function
Band 3 (SLC4A1) in human erythrocytes mediates rapid electrogenic sulfate-chloride exchange, which is important for ion homeostasis and can be altered by chemical modifications. This activity is a model for understanding antiport mechanisms and their regulation.
Environmental and Evolutionary Aspects
Sulfate:chloride antiporter activity is also observed in diverse organisms, such as lobster hepatopancreatic membranes, where it is electrogenic and H+-regulated. In hot spring ecosystems, rapid arsenite oxidation may involve sulfate transport processes. These studies provide evolutionary and ecological insights.
From sulfate:chloride antiporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC26A2 mutation affect sulfate transport? | Point mutation knock-in in chondrocytes |
| What is the role of SLC26A1 in sulfate homeostasis? | Knockout in HEK293 cells |
| Can band 3 be chemically modified to alter antiport? | Overexpression of mutant SLC4A1 in erythroid cells |
| How does proton regulation affect antiporter activity? | Tagged knock-in for pH sensors |
| What genes interact with SLC26A2 in disease? | CRISPR library screening |
| Does overexpression of SLC26A1 increase sulfate uptake? | Overexpression in mammalian cells |
How to Study the sulfate:chloride antiporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive flux assay | Transport of sulfate or chloride | Membrane vesicles from cells |
| Patch-clamp | Electrogenic transport | Electrophysiology of antiporters |
| Site-directed mutagenesis | Functional impact of mutations | SLC26A2 disease variants |
| Chemical modification | Inhibition or activation of transport | Band 3 in erythrocytes |
| RNA-seq | Gene expression levels | Tissue distribution of SLC26A1 |
| Proteomics | Protein abundance and modifications | Characterization of hsat-1 |
| CRISPR knockout | Loss-of-function phenotypes | Sulfate transport studies |
| Overexpression | Gain-of-function effects | SLC26A1 in HEK293 cells |
Transport Assays
Radioactive sulfate or chloride flux assays in membrane vesicles or cells can measure antiporter activity directly. For example, studies in lobster hepatopancreatic vesicles used radioactive tracers to demonstrate electrogenic exchange. Similar assays can be applied to human cells expressing SLC26A1 or band 3.
Electrophysiology
Electrophysiological techniques such as patch-clamp or voltage-clamp can measure the electrogenic nature of sulfate:chloride exchange. The electrogenic exchange in lobster vesicles was characterized using such methods.
Mutagenesis and Chemical Modification
Site-directed mutagenesis and chemical modification can identify residues critical for transport. Band 3-mediated exchange was studied using chemical modifiers. Mutations in DTDST were analyzed to link genotype to phenotype.
Expression Analysis
RNA-seq and proteomics can assess expression levels of SLC26 and SLC4 family members in tissues. The human hsat-1 gene expression was characterized. Such methods help identify tissue-specific roles.
How CRISPR Can Be Used to Study GO:0160044 sulfate:chloride antiporter activity
Knockout
CRISPR knockout of SLC26A2 or SLC26A1 can abolish sulfate:chloride antiporter activity, allowing researchers to study loss-of-function phenotypes such as impaired proteoglycan sulfation. For example, knocking out SLC26A2 in chondrocytes would mimic skeletal dysplasia.
Point Mutation
Introducing patient-specific point mutations (e.g., L483P in DTDST) via CRISPR can recapitulate disease phenotypes and elucidate the impact on transport activity. This approach helps link genotype to molecular function.
Knock-in
Knock-in of tagged versions of SLC26A1 or band 3 enables live-cell imaging and biochemical purification. Tagged knock-in of SLC4A1 can be used to track its localization and interactions.
Overexpression
CRISPR activation or cDNA overexpression of SLC26A1 can increase sulfate:chloride antiporter activity, facilitating transport assays and drug screening. Overexpression in HEK293 cells is a common approach.
How EDITGENE Supports sulfate:chloride antiporter activity Research
Researchers studying sulfate:chloride antiporter activity-related genes often need to determine whether a candidate gene is causally involved in sulfate transport, skeletal development, or ion homeostasis. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for sulfate:chloride antiporter activity research.
Frequently Asked Questions About sulfate:chloride antiporter activity
What is sulfate:chloride antiporter activity?
Sulfate:chloride antiporter activity (GO:0160044) is a molecular function that enables the exchange of chloride and sulfate ions across a membrane, as defined by the reaction chloride(in) + sulfate(out) = chloride(out) + sulfate(in).
What genes are involved in sulfate:chloride antiporter activity?
Key genes include SLC26A1 (hsat-1), SLC4A1 (band 3), and SLC26A2 (DTDST), which encode proteins that mediate this exchange.
Which diseases are linked to sulfate:chloride antiporter activity?
Mutations in SLC26A2 cause skeletal dysplasias such as achondrogenesis type 1B and diastrophic dysplasia due to impaired sulfate transport.
Is sulfate:chloride antiporter activity electrogenic?
Yes, it is electrogenic, as demonstrated in lobster hepatopancreatic membrane vesicles where the exchange generated a net charge movement.
How is sulfate:chloride antiporter activity regulated?
It can be regulated by protons (H+), as shown in lobster vesicles, and by chemical modifications of the transporter, as seen with band 3.
What is the role of SLC26A1 in sulfate transport?
SLC26A1 encodes the human sulfate anion transporter hsat-1, which mediates sulfate transport and likely functions as a sulfate:chloride antiporter.
Can CRISPR be used to study sulfate:chloride antiporter activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study the function of genes like SLC26A2 and SLC26A1 in sulfate transport.
What methods measure sulfate:chloride antiporter activity?
Radioactive flux assays, electrophysiology, and mutagenesis are common methods to measure this activity.
What is the reaction catalyzed by sulfate:chloride antiporter?
The reaction is chloride(in) + sulfate(out) = chloride(out) + sulfate(in), representing a coupled exchange.
Why is sulfate:chloride antiporter activity important for cartilage?
It provides sulfate for proteoglycan sulfation, which is essential for cartilage integrity; defects lead to skeletal dysplasias.
Conclusion
Sulfate:chloride antiporter activity (GO:0160044) is a fundamental membrane transport function that maintains sulfate and chloride homeostasis. Its electrogenic nature and regulation by protons have been demonstrated in diverse systems. The human SLC26A1 and SLC4A1 proteins are key mediators, and mutations in SLC26A2 cause severe skeletal disorders. Studying this activity using CRISPR models and biochemical assays will continue to reveal its roles in health and disease.
References
- 1. Cattey MA et al.. 1992. Electrogenic H(+)-regulated sulfate-chloride exchange in lobster hepatopancreatic brush-border membrane vesicles.. Am J Physiol 262(2 Pt 2):R255-62 PMID: 1539734
- 2. Jennings ML. 1995. Rapid electrogenic sulfate-chloride exchange mediated by chemically modified band 3 in human erythrocytes.. J Gen Physiol 105(1):21-47 PMID: 7537324
- 3. Regeer RR et al.. 2003. Characterization of the human sulfate anion transporter (hsat-1) protein and gene (SAT1; SLC26A1).. DNA Cell Biol 22(2):107-17 PMID: 12713736
- 4. Czarny-Ratajczak M et al.. 2010. New intermediate phenotype between MED and DD caused by compound heterozygous mutations in the DTDST gene.. Am J Med Genet A 152A(12):3036-42 PMID: 21077204
- 5. Rossi A et al.. 1996. Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.. J Biol Chem 271(31):18456-64 PMID: 8702490
- 6. Langner HW et al.. 2001. Rapid oxidation of arsenite in a hot spring ecosystem, Yellowstone National Park.. Environ Sci Technol 35(16):3302-9 PMID: 11529568
- 7. Ibrahim SA et al.. 1990. Ground distribution patterns of selected radioactive, chemical, and physical contaminants from dispersion of U mill tailings.. Health Phys 58(3):321-8 PMID: 2312296
- 8. Wolffram S et al.. 1994. Transport of citrate across the brush border and basolateral membrane of rat small intestine.. Comp Biochem Physiol Physiol 109(1):39-52 PMID: 8076452
